Coronavirus outbreak highlighted vulnerabilities in medical manufacturing supply chain: Fitch Solutions
4 years, 8 months ago

Coronavirus outbreak highlighted vulnerabilities in medical manufacturing supply chain: Fitch Solutions

Firstpost  

New Delhi: With pharmaceutical supply chains under immense pressure due to COVID-19, China’s role as a global ingredient producer has come under scrutiny, Fitch Solutions has said. As per the report, as trade war has heightened discussion over the national security implications of manufacturing new technologies abroad, COVID-19 has highlighted vulnerabilities in the medical manufacturing supply chain, most notably in the US. As well, growing political will amongst major developed economies could encourage governments to offer incentives for companies to re-shore some medical equipment manufacturing. “Outside India, in the US as of August 2019, only 28 percent of the manufacturing facilities making APIs to supply the US market were in the country.

India China Manufacturing Supply  manufacturing  supply  coronavirus  china  pharmaceutical  imports  solutions  medical  chain  drugs  outbreak  vulnerabilities  ingredients  fitch  covid19  india  highlighted  bulk

History of this topic

Chinese Pharma Major Shanghai Pharma Seeking API Imports From India
1 month, 3 weeks ago

Chinese Pharma Major Shanghai Pharma Seeking API Imports From India

ABP News  

Shanghai, China: Chinese pharmaceutical giant Shanghai Pharmaceuticals Holding Co. Ltd is keen on importing active pharmaceutical ingredients from India, and is also planning to invest in the Indian market in an effort to expand its footprint in the generic drugs market. In India, more and more APIs are getting FDA approval, so we are now thinking of importing APIs from …

Pharma Star: India Steering Global Supply Chain Away from China - News18
1 year, 1 month ago

Pharma Star: India Steering Global Supply Chain Away from China - News18

News 18  

India’s pharmaceutical industry is at a pivotal juncture. With its well-established prowess in generic drug manufacturing, it has been called on by the world to build a reliable base for the manufacture of raw materials, which offers an opportunity for India to attract the bulk of the pharmaceutical supply chains away from China. “India has started producing 45 APIs after …

Opinion: India could write the next chapter of global pharma triumph
1 year, 4 months ago

Opinion: India could write the next chapter of global pharma triumph

India Today  

India’s G20 presidency has significant implications for the pharmaceutical industry, focussing on improving global health emergency preparedness, fostering industry collaborations, and harnessing digital health potential. India’s pharma industry has established its position as a global hub for drug manufacturing, bolstered by a well-established domestic production infrastructure and a pool of highly-skilled, cost-effective workforce. New avenues for growth Not surprisingly, global …

Drafting a road map to bolster the pharma sector
1 year, 9 months ago

Drafting a road map to bolster the pharma sector

Hindustan Times  

India is known as the pharmacy of the world, and there are several good reasons why it is called so. The country exports pharma products to over 200 countries, and its domestic pharmaceutical industry includes a strong network of 3,000 drug companies and 10,500 manufacturing units. The meeting, attended by representatives from the Union ministry and state governments, had five …

Budget 2023: An Opportunity To Push India's Pharma Industry Development
1 year, 11 months ago

Budget 2023: An Opportunity To Push India's Pharma Industry Development

News 18  

The Union Budget 2023-24 will be presented on February 1 against the backdrop of a global recessionary fear. Several public sector schemes launched in the past few years, including the Pradhan Mantri Ayushman Bharat Health Infrastructure Mission, have focused on building last-mile infrastructure. Outlining the wishlist for the sector in the upcoming Union Budget, Indian Pharmaceutical Alliance Secretary General Sudarshan …

Chinese are turning to black market for Indian Covid drugs amid surge: Report
2 years ago

Chinese are turning to black market for Indian Covid drugs amid surge: Report

Hindustan Times  

Chinese residents have turned to the black market for generic Covid drugs amid an unprecedented pandemic outbreak in the country, a report said. China approved two Covid-19 antivirals this year – Pfizer’s Paxlovid and Azvudine, an HIV drug from Chinese firm Genuine Biotech- both of which are only available in certain hospitals in China. Covid In China: People wearing face …

Chinese turning to Indian drugs on black market amid Covid spike
2 years ago

Chinese turning to Indian drugs on black market amid Covid spike

India Today  

Chinese nations have now turned to the black market for generic Covid-19 drugs as the country is dealing with an unprecedented outbreak with limited supplies of approved antivirals. China approved two Covid-19 antivirals this year - Pfizer’s Paxlovid and Azvudine, an HIV drug from Chinese firm Genuine Biotech. Topics like “anti-Covid Indian generic drugs sold at 1,000 yuan per box” …

Exporters on edge as raging covid in China derails trade
2 years ago

Exporters on edge as raging covid in China derails trade

Live Mint  

The covid-19 surge in China has triggered concern among Indian exporters as it may add to the softening of demand from Western countries. China, India’s largest trading partner, reported an 11% decline in imports in November, and the latest outbreak could further hit exports of Indian goods. “The covid situation in China is a cause for concern both in terms …

China authorities take over medical supplies production as COVID-19 surges
2 years ago

China authorities take over medical supplies production as COVID-19 surges

The Hindu  

China has requisitioned medical supplies production across the country as millions struggle to obtain basic drugs and testing kits in the face of a surge in Covid-19 cases. At least 11 of 42 test kit makers whose products are licensed by China's medical regulators have had part of their production seized by the government or received orders from the state, …

Made-in-India COVID drugs emerge as life-savers in China, but a Chinese film had predicted so in 2018
2 years ago

Made-in-India COVID drugs emerge as life-savers in China, but a Chinese film had predicted so in 2018

Firstpost  

Dying to Survive, a film from 2018, was quite farsighted in its telling of a future happening. The Chinese comedy-drama starring Xu Zheng, takes inspiration from a true story — of a Chinese leukemia patient Lu Yong who smuggled cheap and generic cancer medicine Remember the 2011 film Contagion starring Matt Damon, Kate Winslet, Gwyneth Paltrow, among others, and how …

Covid cases rising: Indian exporters keeping fingers crossed over China situation
2 years ago

Covid cases rising: Indian exporters keeping fingers crossed over China situation

India TV News  

Covid New Wave: Indian exporters are keeping their fingers crossed on account of rising Covid infections in China and other countries as it could again disrupt supply chains and affect demand for goods. Sahai said that if Chinese industries start shutting down due to rise in Covid cases, it would impact imports of key components for sectors such as pharmaceuticals, …

India@75: Phenomenal journey of the pharma industry
2 years, 1 month ago

India@75: Phenomenal journey of the pharma industry

Hindustan Times  

The Indian pharmaceutical industry has come a long way since the country’s independence. Among private players, Khwaja Abdul Hamied had already set up one of India’s oldest pharma companies, Cipla in 1935; Indravan Modi set up Cadila pharmaceuticals in the early 1950s, Kallam Anji Reddy set up Dr Reddy’s Laboratories in Hyderabad and Bhai Parvinder Singh set up Ranbaxy in …

DC Edit | Time to clean up pharma
2 years, 3 months ago

DC Edit | Time to clean up pharma

Deccan Chronicle  

The Central Drugs Standard Control Organisation has initiated an investigation after the World Health Organisation issued an alert following the death of 66 children in the West African nation of Gambia. It is perhaps for the first time that an Indian drug manufacturer is in the dock for causing deaths in a foreign nation. The $40 billion Indian pharmaceuticals industry …

What is Active Pharmaceutical Ingredient and why is it essential for drug manufacturing?
2 years, 4 months ago

What is Active Pharmaceutical Ingredient and why is it essential for drug manufacturing?

Firstpost  

The COVID-19 pandemic caused a panic among global pharmaceutical manufacturers as the supply of APIs was disrupted from China, the world’s largest producer Active Pharmaceutical Ingredients or APIs are essential to the pharma industry. According to pharmaceutical company Biocon, an API means “the biologically active component of a drug product that produces the intended effects”. The COVID-19 pandemic caused a …

WHO suspends UN supply of Covaxin over manufacturing deficiencies, Bharat Biotech slows down production
2 years, 9 months ago

WHO suspends UN supply of Covaxin over manufacturing deficiencies, Bharat Biotech slows down production

India Today  

In a setback to India’s indigenous vaccine against Covid-19, the World Health Organisation has issued a statement saying that the body is suspending the supply of Bharat Biotech’s Covaxin through UN agencies. A day earlier, Bharat Biotech issued a statement saying the company “announces the temporary slowing down of production of Covaxin across its manufacturing facilities, having completed its supply …

Explained | Why are U.S. COVID-19 vaccines still out of reach in India?
3 years, 2 months ago

Explained | Why are U.S. COVID-19 vaccines still out of reach in India?

The Hindu  

The story so far : More than six months after the government announced it would fast-track clearances for foreign COVID-19 vaccines to India, the indemnity clause is still holding up the import of all American vaccines to India, including those manufactured by Pfizer, Johnson & Johnson and Moderna. If it all any indemnity is to be granted to any company …

COVID-19 and Pharmaceuticals: International & national collaborations will increase India's business prospects
3 years, 3 months ago

COVID-19 and Pharmaceuticals: International & national collaborations will increase India's business prospects

Firstpost  

COVID-19 has been a stark reminder of the importance of uninterrupted access to medicines and health products. As the world’s eleventh largest exporter, India accounted for 2.6 per cent of global pharmaceutical exports in 2019. COVID-19 vaccines being manufactured and distributed by Indian pharmaceutical companies, such as the Serum Institute of India, Bharat Biotech and Dr Reddy’s Laboratories, are being …

India Plans to Revive Dormant API Manufacturing Industry, Cut Over Dependence on China
3 years, 5 months ago

India Plans to Revive Dormant API Manufacturing Industry, Cut Over Dependence on China

News 18  

The Indian pharmaceutical industry is one of the major contributors to the Indian economy and it is the world’s third-largest industry by volume. As the world’s top supplier of bulk drugs and formulations, Indian pharmaceutical plants consistently attract the highest number of FDA approvals outside of the US, and the country submits more than 40 per cent of all global …

Increase in manufacturing capacity of Covid-19 vaccines in India may prove game changer: Biden Admin
3 years, 7 months ago

Increase in manufacturing capacity of Covid-19 vaccines in India may prove game changer: Biden Admin

India Today  

Increase in manufacturing capacity of Covid-19 vaccines in India has the potential to be a game changer well beyond its borders, the Joe Biden Administration said Thursday. That is why we have spoken of the focus on increased manufacturing in India," State Department spokesperson Ned Price told reporters. "The increased manufacturing capacity in India, the volume of capacity has the …

In Talks With Pfizer, Johnson & Johnson, and Moderna to Source, Manufacture Vaccines in India: Centre
3 years, 7 months ago

In Talks With Pfizer, Johnson & Johnson, and Moderna to Source, Manufacture Vaccines in India: Centre

News 18  

Discussions are underway with major pharma companies about sourcing and possibly manufacturing their COVID-19 jabs locally while India is looking forward to WHO’s nod for Bharat Biotech’s indigenously developed vaccine, Foreign Secretary Harsh Vardhan Shringla said on Thursday. Addressing the World Health Organisation’s South-East Asia Regional Health Partners’ Forum on COVID-19 he also said the government has worked with key …

With Eye on China’s Vaccine Diplomacy, India & US Must Collaborate to Meet Needs of Developing World
3 years, 7 months ago

With Eye on China’s Vaccine Diplomacy, India & US Must Collaborate to Meet Needs of Developing World

News 18  

External Affairs Minister S. Jaishankar’s visit to the US comes at a time when the second wave of the Wuhan virus is ravaging India, the situation on the border in Ladakh is stalemated, the US policy towards China is hardening. A fall out of shared maritime security concerns opens up the Indian defence market more to the US military equipment, …

The AIDS fight offers a COVID vaccine patent pathway
3 years, 7 months ago

The AIDS fight offers a COVID vaccine patent pathway

The Hindu  

In order to achieve global herd immunity and prevent new strains of COVID-19 from emerging, possibly for years to come, vaccines need to be affordable and available in massive quantities throughout the globe. The United Nations’ Medicines Patent Pool and the World Health Organization’s COVID-19 Technology Access Pool are important tools in an effort to promote voluntary licensing for COVID …

Foreign countries, companies ramp up delivery of Covid aid to India
3 years, 8 months ago

Foreign countries, companies ramp up delivery of Covid aid to India

India Today  

Several countries and leading global companies have ramped up their production and delivery of emergency assistance to help India which is facing a devastating second wave of the coronavirus pandemic. China China is also accelerating its production and delivery of 40,000 more oxygen generators ordered by India and 61 cargo flights operated between the two countries in the last two …

India's second coronavirus wave causing global 'crisis' as COVID-19 vaccine supplies disrupted
3 years, 8 months ago

India's second coronavirus wave causing global 'crisis' as COVID-19 vaccine supplies disrupted

ABC  

The global vaccine supply chain, already under extreme pressure, has been thrown into disarray by the COVID-19 crisis devastating India. Key points: So far, India has been unable to supply 80 million of the doses it had agreed to give COVAX COVAX is a collaboration of organisations that was set up to share vaccines fairly around the world India falling …

Merck Pharma to sign licensing pacts with 5 Indian drug firms for COVID-19 drug candidate molnupiravir
3 years, 8 months ago

Merck Pharma to sign licensing pacts with 5 Indian drug firms for COVID-19 drug candidate molnupiravir

Firstpost  

Molnupiravir is an oral antiviral agent, currently being studied in a Phase 3 trial for the treatment of non-hospitalised COVID-19 patients New Delhi: Drug firm MSD has decided to enter into voluntary licensing agreements for investigational oral antiviral drug candidate ‘molnupiravir’, which is being studied for the treatment of COVID-19, with Indian drug firms Sun Pharma, Cipla, Dr Reddy’s, Emcure …

Biden Administration Defends Ban On Export Of Vaccine Raw Material Says 'Americans First'
3 years, 8 months ago

Biden Administration Defends Ban On Export Of Vaccine Raw Material Says 'Americans First'

ABP News  

New Delhi: Responding to the request to lift the ban on the export of raw material for the manufacture of COVID-19 vaccine which in turn threatens to slow India's vaccination drive, a State Dept. A State Department spokesperson Ned Price said: ".the United States first and foremost is engaged in an ambitious and effective and, so far, successful effort to …

US Defends Export Ban of Covid Vaccine Raw to India, Says 'Americans First'
3 years, 8 months ago

US Defends Export Ban of Covid Vaccine Raw to India, Says 'Americans First'

News 18  

Defending US’ restrictions on the export of key raw materials for the manufacture of COVID-19 vaccine that threatens to slow India’s vaccination drive, a senior State Department official has said the Biden administration’s first obligation is to take care of the requirements of the American people. When asked when the Biden administration would decide on India’s request to lift a …

U.S. defends restrictions on export of COVID-19 vaccine raw materials amid India's request to lift ban
3 years, 8 months ago

U.S. defends restrictions on export of COVID-19 vaccine raw materials amid India's request to lift ban

The Hindu  

Defending U.S.’ restrictions on the export of key raw materials for the manufacture of COVID-19 vaccine that threatens to slow India’s vaccination drive, a senior State Department official has said the Biden administration’s first obligation is to take care of the requirements of the American people. When asked when the Biden administration would decide on India’s request to lift a …

US defends restrictions on export of COVID-19 vaccine raw materials amid India's request to lift ban
3 years, 8 months ago

US defends restrictions on export of COVID-19 vaccine raw materials amid India's request to lift ban

India TV News  

Defending US' restrictions on the export of key raw materials for the manufacture of COVID-19 vaccine that threatens to slow India's vaccination drive, a senior State Department official has said the Biden administration's first obligation is to take care of the requirements of the American people. When asked when the Biden administration would decide on India''s request to lift a …

'Understand India's pharmaceutical needs': US to consider lifting ban on Covid-19 vaccine raw material supply
3 years, 8 months ago

'Understand India's pharmaceutical needs': US to consider lifting ban on Covid-19 vaccine raw material supply

India TV News  

The Biden administration has conveyed to New Delhi that it understands India's pharmaceutical requirements and promised to give the matter a due consideration, observing that the current difficulty in the export of critical raw materials needed to manufacture COVID-19 vaccines is mainly due to an Act that forces American companies to prioritise domestic consumption. During his meetings with the US …

We understand India’s pharmaceutical requirements: Joe Biden
3 years, 8 months ago

We understand India’s pharmaceutical requirements: Joe Biden

The Hindu  

The Biden administration has conveyed to New Delhi that it understands India’s pharmaceutical requirements and promised to give the matter a due consideration, observing that the current difficulty in the export of critical raw materials needed to manufacture COVID-19 vaccines is mainly due to an Act that forces American companies to prioritise domestic consumption. President Joe Biden and his predecessor …

India's Covid-19 cases mount but uncertainty over US export ban on vaccine raw materials continues
3 years, 8 months ago

India's Covid-19 cases mount but uncertainty over US export ban on vaccine raw materials continues

India Today  

Serum Institute of India's Chief Executive Officer, Adar Poonawalla recently sought US President Joe Biden's intervention in lifting a ban on raw materials that India imports from the US. SoS FROM POONAWALLA On April 16, Adar Poonawalla, in what appeared to be a desperate appeal, tweeted: "Respected @POTUS, if we are to truly unite in beating this virus, on behalf …

India to waive import duty on Covid-19 vaccines: Report
3 years, 8 months ago

India to waive import duty on Covid-19 vaccines: Report

India Today  

India will waive its 10 per cent customs duty on imported Covid-19 vaccines, a senior government official told Reuters on Monday, as it tries to boost supplies to counter a dramatic surge in coronavirus cases. Imports of Russia's Sputnik V vaccine are due to arrive soon and the government has also urged Pfizer, Moderna and Johnson and Johnson to sell …

Indian vaccine maker asks US to ease export curbs
3 years, 8 months ago

Indian vaccine maker asks US to ease export curbs

Associated Press  

NEW DELHI — The chief executive of Serum Institute of India, the world’s largest maker of vaccines and a critical supplier of the U.N.-backed COVAX facility, asked President Joe Biden on Twitter to lift the U.S. embargo on exporting raw materials needed to make the jabs. Stéphane Bancel, chief executive officer for Moderna, said Tuesday in an online event that …

Despite Spurt In Cases, Govt Worried About Banning Commercial Export of Covid-19 Vaccine
3 years, 8 months ago

Despite Spurt In Cases, Govt Worried About Banning Commercial Export of Covid-19 Vaccine

News 18  

A special report by Moneycontrol has confirmed that the Centre has decided against banning the commercial export of Covid-19 vaccines by the two manufacturers based in India. Reports of acute shortage of vaccine doses in many States also prompted calls to stop the export of the Covishield vaccine manufactured by Pune’s Serum Institute of India and Covaxin, made by Hyderabad-based …

Coronavirus | India bans export of Remdesivir
3 years, 8 months ago

Coronavirus | India bans export of Remdesivir

The Hindu  

Centre has prohibited the exports of injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients in an order issued on Sunday stating that there has been a sudden spike in demand for injection Remdesivir used in treatment of COVID patients. “India is witnessing a recent surge in COVID cases and there is a potential of further increase in demand for injection Remdesivir …

India bans remdesivir exports as COVID-19 cases surge
3 years, 8 months ago

India bans remdesivir exports as COVID-19 cases surge

Al Jazeera  

The health ministry says a ban to be in place until the ‘situation improves’ as India sees the sixth record daily rise in new infections in seven days. India has banned the export of antiviral drug remdesivir and its active pharmaceutical ingredients as demand rocketed amid a record surge in COVID-19 infections and led to shortages in many parts of …

India delays big exports of AstraZeneca vaccine as Covid-19 cases surge: Report
3 years, 9 months ago

India delays big exports of AstraZeneca vaccine as Covid-19 cases surge: Report

India Today  

India has put a temporary hold on all major exports of the AstraZeneca coronavirus vaccine made by the Serum Institute of India to meet demand at home as infections rise, two sources told Reuters. The move will also affect supplies to the GAVI/WHO-backed COVAX vaccine-sharing facility through which more than 180 countries are expected to get doses, one of the …

Ocugen seeks to sell 100 million doses of 'Made in India' Covaxin in US
3 years, 9 months ago

Ocugen seeks to sell 100 million doses of 'Made in India' Covaxin in US

India Today  

Ocugen Inc seeks to sell 100 million doses of India’s state-backed Covid-19 vaccine Covaxin in the United States this year, the US firm’s chief executive Shankar Musunuri told Reuters on Monday. Musunuri said Ocugen aimed to launch the two-dose vaccine in the United States in the second quarter of 2021, initially with imported shots before beginning production there. Musunuri said …

U.S. curbs on raw material exports could dent new Quad alliance's vaccine push
3 years, 9 months ago

U.S. curbs on raw material exports could dent new Quad alliance's vaccine push

The Hindu  

The U.S.-backed Quad alliance aims to invest in India’s pharmaceutical capacity as it looks to ramp up COVID vaccine output, but U.S. curbs on exports of key materials could hamper that effort, sources say. The White House said last week it had used the U.S. Defence Production Act — which prevents export of materials to prioritise local production — to …

US says it looks forward to 'overarching' MoU to boost health co-operation with India
3 years, 10 months ago

US says it looks forward to 'overarching' MoU to boost health co-operation with India

Firstpost  

The two countries are working together on developing diagnostics, therapeutics and vaccines to combat COVID-19, said a US state department spokesperson Washington: The US has said it is looking forward to an ‘overarching’ memorandum of understanding to enhance health partnership with India and asserted that the cooperation between the two countries on COVID-19 builds on decades of successful collaboration in …

Coronavirus | Serum Institute of India, UNICEF enter into long-term supply pact for COVID-19 vaccines
3 years, 11 months ago

Coronavirus | Serum Institute of India, UNICEF enter into long-term supply pact for COVID-19 vaccines

The Hindu  

The Serum Institute of India and UNICEF have entered into a long-term supply agreement for the AstraZeneca/Oxford and the Novavax vaccines, with the UN children’s agency saying it will have access to up to 1.1 billion doses of vaccines for around 100 countries. While Oxford-AstraZeneca's Covishield is being manufactured by Pune-based Serum Institute, and the Novavax is being produced by …

China still ‘largest source of critical items’ for India
3 years, 11 months ago

China still ‘largest source of critical items’ for India

The Hindu  

China still remains the largest source of critical imports for India, from mobile phone components to pharmaceutical ingredients, and India is working on a multi-pronged strategy to reduce this reliance, which is a bigger concern than the imbalance in trade. When somebody controls your production, that is a sentiment which raises concern.” PLI scheme Mr. Chadha said that India was …

India, a vaccine hub for the world! 92 countries request for stock
3 years, 11 months ago

India, a vaccine hub for the world! 92 countries request for stock

India TV News  

Ninety-two countries have approached India for Covid-19 vaccines, bolstering New Delhi's credentials as the vaccine hub of the world. Many other countries seeking Made-in-India vaccines According to a Reuters report from Sao Paulo, Health Minister Eduardo Pazuello said the documentation is ready for bringing the AstraZeneca-Oxford University vaccine being produced at the Serum Institute of India. Meanwhile the Bolivian government …

India, ‘pharmacy of the world’, starts exporting COVID vaccines
3 years, 11 months ago

India, ‘pharmacy of the world’, starts exporting COVID vaccines

Al Jazeera  

First shipment sent to Bhutan as ‘supplies under grant assistance’ to be exported to other neighbouring nations. India has started exporting coronavirus vaccines with a shipment to the neighbouring Himalayan kingdom of Bhutan, the Ministry of External Affairs said, as the so-called “pharmacy of the world” looks to bolster its vaccine diplomacy. Many low and middle-income countries are relying on …

Russia, China trying to disrupt our vaccine supply chain: US counter-intelligence chief
3 years, 11 months ago

Russia, China trying to disrupt our vaccine supply chain: US counter-intelligence chief

India Today  

The US counter-intelligence chief said on Tuesday he was worried about threats from China and Russia to disrupt the coronavirus vaccine supply chain in the United States. William Evanina, director of the US National Counterintelligence and Security Center, told an online Washington Post event that US adversaries were trying to interfere with Operation Warp Speed, the US government operation distributing …

Hackers target coronavirus vaccine makers on darkweb
4 years ago

Hackers target coronavirus vaccine makers on darkweb

India TV News  

At a time when country after country is preparing to begin mass vaccination against coronavirus, cyber criminal gangs are also pushing themselves to produce counterfiet vaccines to fraud people. Companies like Pfizer, Sputnik, BioNTech are trying to produce vaccines so as to satisfy the need of the world, companies involving in their manufacturing, production, logistics are on the target of …

China’s irritated trade partners push back on COVID-19 food tests
4 years, 1 month ago

China’s irritated trade partners push back on COVID-19 food tests

Al Jazeera  

Canada calls China’s rejection of food products that had positive tests for COVID-19 ‘unjustified trade restrictions’. In a World Trade Organization meeting on November 5-6, Canada called China’s testing of imported foods and rejection of products that had positive nucleic acid tests “unjustified trade restrictions” and urged it to stop the practice, said a Geneva-based trade official briefed on the …

Covid vaccine: India looking to work with other nations for supply & research
4 years, 2 months ago

Covid vaccine: India looking to work with other nations for supply & research

Live Mint  

NEW DELHI: With many parts of the world seeing a fresh uptick in the number of covid-19 cases, India on Friday said it was looking forward to research collaboration in vaccine development and could also explore joint production of vaccines in some countries. Indian foreign secretary Harsh Vardhan Shringla who briefed a group of diplomats based in New Delhi on …

5 takeaways: AP/FRONTLINE investigate medical supply chains
4 years, 3 months ago

5 takeaways: AP/FRONTLINE investigate medical supply chains

Associated Press  

From the very moment the coronavirus pandemic reached America’s shores, the country was unprepared. Medical supply chains are the fragile lifelines between raw materials and manufacturers overseas, and health care workers on COVID-19 front lines in the U.S. Their catastrophic collapse was one of the country’s most consequential failures to control the virus. ___ EDITOR’S NOTE — This story is …

Discover Related